All Insights
Showing 1 - 12 of 548
Competition, antitrust and trade
The UK CMA updates its merger remedies guidance
The regulator may be more open to behavioural remedies, but only where it is satisfied they are effective and proportionate
Competition, antitrust and trade
Will there be a more streamlined UK merger control process?
The CMA's procedural overhaul offers merging parties more influence over timing and remedies, but whether it will shorten reviews remains
Competition, antitrust and trade
What does the Getty Images/Shutterstock decision tell business about how the CMA approaches mergers in the UK?
Competition and Markets Authority rejects Getty/Shutterstock remedies, despite focus on growth
Competition, antitrust and trade
UK government consults on major reforms to competition processes
The government's growth agenda underlies a set of sweeping and probably controversial proposals
Life Sciences and Healthcare
Draft EU medtech revisions adjust importer and distributor roles to support supply chain resilience
Digital obligations, leaner repackaging rules and new shortage reporting tools may evolve supply chain responsibilities
Life Sciences and Healthcare
Planned EU medtech changes and codified Helsinki procedure support consistent qualification and classification
EU coordination, expert panel opinions and targeted down classification are proposed to harmonise risk based outcomes
Life Sciences and Healthcare
EU drug agency to take broader coordinating role in devices and diagnostics in latest proposal
Expert panel support, shortage coordination and combined study procedures strengthen the EMA's oversight of devices
Regulatory Outlook
Competition | UK Regulatory Outlook January 2026
Digital markets | Merger remedies | Civil engineering | Regulatory action plan | Subsidy Control Act
Life Sciences and Healthcare
Proposed EU medtech laws seek more predictable and efficient notified body oversight
Structured dialogue, streamlined sampling, extended audits and SME‑friendly fees to reshape device conformity assessment
Life Sciences and Healthcare
EU revised device rules rebalance compliance towards simplification and proportionality
Commission proposal would streamline MDR and IVDR duties with flexible evidence, timeless certificates and tailored risk rules
Knowledge Notes
What business law changes can the UK expect in 2026?
Osborne Clarke's Knowledge Team looks at what's in store for business
The Digital Markets Competition and Consumers Act (DMCCA)
UK CMA finalises guidance on price transparency under DMCCA and begins enforcement action
From holidays to fashion, fourteen sectors under scrutiny as the regulator finalises guidance on total price requirements
